Comparison 3. Clinical improvement.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Reaching Fontaine stage II | 2 | 124 | Risk Difference (M‐H, Fixed, 95% CI) | 0.33 [0.19, 0.47] |
2 Reaching Fontaine stage III | 2 | 206 | Risk Difference (M‐H, Random, 95% CI) | 0.07 [‐0.24, 0.38] |
3 Ulcer healing and hypertension | 2 | 72 | Risk Difference (M‐H, Fixed, 95% CI) | ‐0.54 [‐0.73, ‐0.35] |
3.1 Hypertensives | 1 | 44 | Risk Difference (M‐H, Fixed, 95% CI) | ‐0.57 [‐0.80, ‐0.33] |
3.2 Non‐hypertensives | 1 | 28 | Risk Difference (M‐H, Fixed, 95% CI) | ‐0.5 [‐0.82, ‐0.18] |